Search

Otovent new app launched – come and explore Otopia!

Otovent proudly launches their new fun, easy to use app to help track Otovent use.

Minimise waiting times with Peptest!

In laryngopharyngeal reflux (LPR), refluxed stomach contents travel up the oesophagus and reach the larynx, causing chronic extra-gastrointestinal symptoms such as a persistent cough, hoarseness or difficulty swallowing, meaning it is often attributed to ENT problems.

DP Medical secures DIFRA Instrumentation distribution deal for UK and Ireland

Leading healthcare supplier, DP Medical Systems Ltd, has been named as the exclusive UK and Ireland distributor for DIFRA Instrumentation – one of the world’s leading creators of diagnostic balance disorder equipment.

MED-EL revolutionises cochlear implantation with unparalleled synchrotron dataset of temporal bones

MED-EL, a leading innovator in the field of cochlear implant research and development, has announced an agreement with the Western University (London, Canada) and Mitacs to gain exclusive access to an extraordinary synchrotron dataset of temporal bones.

BHM-Tech takes over the Sophono product line from Medtronic

We are pleased to announce, that we have taken over the global support of the Sophono hearing system from owner Medtronic.

Peptest Q&A

Untreated reflux can cause inflammation, scarring, narrowing and precancerous changes in the oesophagus and larynx, and may increase the risk of asthma and sleep apnoea.

Neuromod Devices’ €30m funding powers Lenire expansion

Neuromod Devices, the global technology business behind scientifically proven tinnitus treatment technology, Lenire, closed €30m funding to expand availability of the groundbreaking tinnitus intervention.

VACANCY: Lecturer/Senior Lecturer in Audiology

You would work as part of a team and primarily deliver high quality teaching and training across a range of programmes based on your area of specialism

Get 20% off your ticket to the Tinnitus Conference 2023

Join Tinnitus UK for their fourth virtual Tinnitus Conference with 20 sessions presenting the latest information and research from world leaders at the forefront of tinnitus and tinnitus support.

Interacoustics introduces a new diagnostic test at EUHA

Interacoustics is happy to introduce the Audible Contrast Threshold (ACT™) test; a new, diagnostic test to support the number one challenge with hearing loss: difficulty hearing speech in background noise.

A triple threat: showcasing Peptest at three ENT conferences

BIOHIT HealthCare is thrilled to be attending three prestigious otorhinolaryngology conferences over the next few weeks.

VACANCY: Audiology Partner – Bexleyheath

Grow your own business, look after your private and NHS customers, serve your community, create an asset for your family’s future and enjoy the profits of all your hard work.